| Q36742916 | 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma |
| Q38815325 | 64Cu-Labeled Gp2 Domain for PET Imaging of Epidermal Growth Factor Receptor |
| Q27313571 | A computer-assisted 3D model for analyzing the aggregation of tumorigenic cells reveals specialized behaviors and unique cell types that facilitate aggregate coalescence |
| Q28475822 | A kernelisation approach for multiple d-Hitting Set and its application in optimal multi-drug therapeutic combinations |
| Q35692849 | A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model |
| Q27345313 | A small molecule with anticancer and antimetastatic activities induces rapid mitochondrial-associated necrosis in breast cancer |
| Q28272830 | ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway |
| Q30764156 | Activated tumor cell integrin αvβ3 cooperates with platelets to promote extravasation and metastasis from the blood stream |
| Q38967805 | Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling. |
| Q39659310 | Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment |
| Q37218012 | Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells |
| Q36428301 | An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis |
| Q35671197 | Analysis of TP53 mutation status in human cancer cell lines: a reassessment |
| Q47637451 | Application of a co‑expression network for the analysis of aggressive and non‑aggressive breast cancer cell lines to predict the clinical outcome of patients |
| Q33680687 | Arrest-defective-1 protein (ARD1): tumor suppressor or oncoprotein? |
| Q47644139 | Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line. |
| Q35660790 | B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation |
| Q55652019 | B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer. |
| Q34173535 | Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells |
| Q24296427 | CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo |
| Q37469514 | CREB3L1 is a metastasis suppressor that represses expression of genes regulating metastasis, invasion, and angiogenesis |
| Q34176395 | CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer |
| Q27025564 | Calcium influx pathways in breast cancer: opportunities for pharmacological intervention |
| Q33882549 | Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. |
| Q37296811 | Cathepsin L inhibition by the small molecule KGP94 suppresses tumor microenvironment enhanced metastasis associated cell functions of prostate and breast cancer cells |
| Q39638952 | Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells |
| Q36194380 | Chemotherapy targeting by DNA capture in viral protein particles |
| Q33914726 | Continued use of MDA-MB-435, a melanoma cell line, as a model for human breast cancer, even in year, 2014. |
| Q37632175 | DJ-1 upregulates breast cancer cell invasion by repressing KLF17 expression |
| Q37679939 | DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis |
| Q35121612 | DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancer |
| Q36204976 | DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination |
| Q34042660 | DNAJB6 induces degradation of beta-catenin and causes partial reversal of mesenchymal phenotype |
| Q33551239 | Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. |
| Q36820588 | Development of a preclinical therapeutic model of human brain metastasis with chemoradiotherapy. |
| Q34076147 | Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis |
| Q34539310 | Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice |
| Q36210416 | Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis |
| Q33636107 | Discovery of antitubulin agents with antiangiogenic activity as single entities with multitarget chemotherapy potential |
| Q34652699 | E47 and Id1 interplay in epithelial-mesenchymal transition |
| Q39584487 | EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice |
| Q34635316 | Effect of soy isoflavones on the growth of human breast tumors: findings from preclinical studies |
| Q38029548 | Effects of omega-3 fatty acids on progestin stimulation of invasive properties in breast cancer |
| Q35910960 | Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor |
| Q36387871 | Erythropoietin-driven signalling and cell migration mediated by polyADP-ribosylation |
| Q90294103 | Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8 |
| Q35973424 | Estrogen receptor-beta and breast cancer: translating biology into clinical practice |
| Q38846310 | Eupolyphaga sinensis Walker Ethanol Extract Suppresses Cell Growth and Invasion in Human Breast Cancer Cells |
| Q58617444 | Evaluation genotypes of cancer cell lines HCC1954 and SiHa by short tandem repeat (STR) analysis and DNA sequencing |
| Q35971203 | Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines. |
| Q37610995 | Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix. |
| Q36688951 | FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies |
| Q37624816 | Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer |
| Q37571698 | Ghrelin and Breast Cancer: Emerging Roles in Obesity, Estrogen Regulation, and Cancer |
| Q34836999 | Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines |
| Q35571699 | HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs |
| Q41127921 | Histone deacetylase activity mediates acquired resistance towards structurally diverse HSP90 inhibitors |
| Q34412950 | Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition |
| Q36497267 | Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis |
| Q24613508 | Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells |
| Q36700083 | Identification of Potential Drug Targets in Cancer Signaling Pathways using Stochastic Logical Models |
| Q28394296 | Identification of novel drugs to target dormant micrometastases |
| Q34519479 | In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas. |
| Q38074351 | In vivo animal models for studying brain metastasis: value and limitations |
| Q37964451 | Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance |
| Q34152723 | Individual and combined soy isoflavones exert differential effects on metastatic cancer progression |
| Q38869800 | Inhibition of breast cancer cell migration by activation of cAMP signaling |
| Q33818935 | Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation |
| Q36220525 | Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis |
| Q35042972 | Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy |
| Q37344824 | Integrin α(v)β₃-targeted radiotracer (99m)Tc-3P-RGD₂ useful for noninvasive monitoring of breast tumor response to antiangiogenic linifanib therapy but not anti-integrin α(v)β₃ RGD₂ therapy |
| Q35880044 | Integrin β4 regulates SPARC protein to promote invasion. |
| Q35310967 | Intradomain cleavage of inhibitory prodomain is essential to protumorigenic function of membrane type-1 matrix metalloproteinase (MT1-MMP) in vivo. |
| Q39818232 | KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility. |
| Q37249506 | Kisspeptin/KISS1R System in Breast Cancer |
| Q35739798 | Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer. |
| Q35048886 | Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer |
| Q35562786 | Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulation |
| Q43049711 | MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells |
| Q38023237 | Maspin: molecular mechanisms and therapeutic implications |
| Q24606871 | Met receptors induce Sam68-dependent cell migration by activation of alternate extracellular signal-regulated kinase family members |
| Q47120854 | Metabolomics guided pathway analysis reveals link between cancer metastasis, cholesterol sulfate, and phospholipids |
| Q28394526 | Metastasis suppressor genes at the interface between the environment and tumor cell growth |
| Q36000051 | Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A. |
| Q33967256 | MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. |
| Q36638143 | Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. |
| Q36254122 | Molecular mechanisms mediating metastasis of hypoxic breast cancer cells |
| Q42514809 | Multidimensional phenotyping of breast cancer cell lines to guide preclinical research |
| Q35770239 | Neuropilin-2 regulates α6β1 integrin in the formation of focal adhesions and signaling |
| Q34187531 | Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging |
| Q37029394 | Nuclear DNA methylation and chromatin condensation phenotypes are distinct between normally proliferating/aging, rapidly growing/immortal, and senescent cells |
| Q36266131 | Organ-specific isogenic metastatic breast cancer cell lines exhibit distinct Raman spectral signatures and metabolomes. |
| Q38028571 | Orthotopic mouse models expressing fluorescent proteins for cancer drug discovery |
| Q38703517 | Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity |
| Q33779210 | PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo |
| Q39376892 | Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs |
| Q36866352 | Pre-osteoblastic MC3T3-E1 cells promote breast cancer growth in bone in a murine xenograft model. |
| Q39021852 | Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer |
| Q33731681 | Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes |
| Q34141711 | Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues |
| Q36852171 | Procollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis |
| Q34615210 | Protein kinase CK2 is a central regulator of topoisomerase I hyperphosphorylation and camptothecin sensitivity in cancer cell lines |
| Q39343190 | Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins |
| Q36403091 | Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells |
| Q34259005 | Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. |
| Q35678603 | Real-time imaging of tumor progression in a fluorescent orthotopic mouse model of thyroid cancer |
| Q28649561 | Registered report: Widespread potential for growth factor-driven resistance to anticancer kinase inhibitors |
| Q34989008 | Regulation of breast cancer cell motility by T-cell lymphoma invasion and metastasis-inducing protein. |
| Q27910523 | Reproducibility: changing the policies and culture of cell line authentication |
| Q34025516 | Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo |
| Q45354950 | Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells |
| Q37684611 | SIN3A and SIN3B differentially regulate breast cancer metastasis |
| Q37671842 | SN-38-cyclodextrin complexation and its influence on the solubility, stability, and in vitro anticancer activity against ovarian cancer |
| Q39570285 | Selective formation of covalent protein heterodimers with an unnatural amino acid |
| Q37310963 | Serially heterotransplanted human prostate tumours as an experimental model |
| Q35591707 | Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer |
| Q35551964 | Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells |
| Q33889288 | Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line |
| Q37074134 | Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein |
| Q34091068 | Stat3 mediates expression of autotaxin in breast cancer |
| Q35645355 | Subsets of ATP-sensitive potassium channel (KATP) inhibitors increase gap junctional intercellular communication in metastatic cancer cell lines independent of SUR expression. |
| Q34430583 | Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1 |
| Q37396653 | Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action |
| Q24624489 | Synthesis of site-specific antibody-drug conjugates using unnatural amino acids |
| Q38977711 | Synuclein gamma protects HER2 and renders resistance to Hsp90 disruption |
| Q34033382 | Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36, a variant of ER-alpha. |
| Q36144913 | Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer |
| Q40132191 | Targeting activated integrin alphavbeta3 with patient-derived antibodies impacts late-stage multiorgan metastasis. |
| Q46312467 | Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment |
| Q36511919 | The TRAIL to targeted therapy of breast cancer |
| Q35348193 | The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis |
| Q36368931 | The hypoxic tumor microenvironment: A driving force for breast cancer progression |
| Q36547313 | The legumain protease-activated auristatin prodrugs suppress tumor growth and metastasis without toxicity |
| Q38246634 | The role and therapeutic potential of the autotaxin-lysophosphatidate signalling axis in breast cancer |
| Q34786592 | The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway |
| Q33988083 | Thrombospondin-1 (TSP-1) Stimulates Expression of Integrin alpha6 in Human Breast Carcinoma Cells: A Downstream Modulator of TSP-1-Induced Cellular Adhesion |
| Q37438581 | Thrombospondin-1 (TSP-1) up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) production in human tumor cells: exploring the functional significance in tumor cell invasion |
| Q36495792 | Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer |
| Q35309992 | Unfolded protein response is required in nu/nu mice microvasculature for treating breast tumor with tunicamycin |
| Q39715058 | Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines |
| Q36720975 | Using Pharmacokinetic Profiles and Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Early Signaling Changes Following Integrin-Linked Kinase Inhibition in an In Vivo Model |
| Q35621527 | VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors |
| Q35001420 | Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inh |
| Q28751757 | Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities |
| Q33691999 | Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol |
| Q37225088 | Ziyuglycoside II inhibits the growth of human breast carcinoma MDA-MB-435 cells via cell cycle arrest and induction of apoptosis through the mitochondria dependent pathway |
| Q37691916 | c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer |